US Bladder Cancer Market

1. US Bladder Cancer Market Size, Share & Trends Analysis Report and Forecast, 2022-2028 The US bladder cancer market is estimated to grow modestly at a CAGR of around 9.7% during the forecast period. The US contributes significantly to the growth of the bladder cancer treatment market in North America. The increasing aging population across the country is augmenting the growth of the market. According to the American Cancer Society, bladder cancer occurs mainly in older people, with an average age at the time of diagnosis being 73 years. US Census Bureau estimated that people aged over 65 years represent around 15% of the total population of the country in 2015. This share is further estimated to reach 21% by 2030 and 24% by 2060. Get Free Sample link @ https://www.omrglobal.com/request-sample/us-bladder- cancer-market Bladder cancer is the fourth most common cancer in men; however, it is less common in women. American Cancer Society has provided bladder cancer statistics for 2019 in the US. The society estimates that around 80,470 new cases of bladder cancer will be diagnosed in the country, of which 61,700 will be in men and 18,770 will be in women. This prevalence of bladder cancer will lead to mortalities across the country. The US consists of some of the key players of the bladder cancer market such as Merck & Co, Inc., Pfizer, Inc., and Spectrum Pharmaceuticals, Inc., which further augments the growth of the market in the country. A https://www.omrglobal.com/industry-reports/us-bladder-cancer-market full report of US Bladder Cancer Market available @ Market Coverage Market number available for – 2022-2028 Base year- 2021 Forecast period- 2022-2028 Segment Covered- By Source, By Product Type, By Applications Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others Market Segmentation US Bladder Cancer Market by Cancer Type o Transitional Cell Bladder Cancer/ Urothelial Carcinoma

2. o Squamous Cell Bladder Cancer o Adenocarcinoma o Others (Sarcomas, Carcinoma in Situ) US Bladder Cancer Market by Diagnosis o Cystoscopy o Biopsy o Urinalysis o Urine Cytology o Intravenous Pyelogram (IVP) o Others (Biomarkers) US Bladder Cancer Market by Treatment o Surgery o Chemotherapy o Immunotherapy o Radiation Therapy o Others (Targeted Therapy) Company Profiles o Astellas Pharma Inc. o AstraZeneca PLC o Bayer AG o Bristol-Myers Squibb Co. o Eli Lilly and Co. o EMD Serono, Inc. o F. Hoffmann-La Roche Ltd. o Genentech Inc. o GlaxoSmithKline Plc

3. o Johnson & Johnson Services, Inc. o Merck & Co., Inc. o Pfizer Inc. o Spectrum Pharmaceuticals, Inc. o Taris Biomedical LLC The Report Covers Comprehensive research methodology of the US bladder cancer market. This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the US bladder cancer market. Insights about market determinants which are stimulating the US bladder cancer market. Detailed and extensive market segments with regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-bladder-cancer-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com

4. Contact no: +91 780-304-0404